BioWorld Asia

March 24, 2010

Wilex Enters €20M Standby Equity Deal with Yorkville

Yorkville Advisors LLC expanded its already large footprint in European biotechnology by entering another standby equity distribution agreement. (BioWorld International) BioWorld International Correspondent Yorkville Advisors LLC expanded its already large footprint in European biotechnology by entering another standby equity distribution agreement. Read More

GW Pharma Enters Home Stretch for Launch of MS Drug Sativex

Variations in Gene Regulation More than Those in the Genes

Connexios Aspires to Become the 'Jewel' of India's Biotechs

Agennix Brings in $13M to Keep Phase III Cancer Trials Moving

U.S., EU Regulators Differ on Suspending Use of Rotarix

Vectura Shares Fall as Novartis Returns Part of Asthma Drug

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Jan 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 9, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld Science

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

Development and characterization of anti-CD19 in vivo CAR T therapy

BioWorld Science

Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...

Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome

BioWorld Science

The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...